Free Trial

Rep. David Taylor Buys Procter & Gamble Company (The) (NYSE:PG) Stock

Procter & Gamble logo with Consumer Staples background

Key Points

  • Representative David Taylor bought between $1,001 and $15,000 in Procter & Gamble Company (NYSE:PG) stock, as disclosed on October 07th.
  • Procter & Gamble's stock is currently down 1.2%, with a market capitalization of $352.64 billion and a current PE ratio of 23.14.
  • Insider trading activity included CEO Jon R. Moeller selling 11,684 shares for over $1.77 million, representing a decrease in their ownership position.
  • MarketBeat previews top five stocks to own in November.

Representative David Taylor (R-Ohio) recently bought shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on October 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Procter & Gamble stock on September 22nd. The trade occurred in the Representative's "DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)" account.

Representative David Taylor also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of American Electric Power NASDAQ: AEP on 9/22/2025.
  • Sold $1,001 - $15,000 in shares of Lam Research NASDAQ: LRCX on 9/22/2025.
  • Purchased $1,001 - $15,000 in shares of Kroger NYSE: KR on 9/22/2025.
  • Sold $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOGL on 9/3/2025.
  • Purchased $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 9/3/2025.
  • Purchased $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
  • Purchased $1,001 - $15,000 in shares of Marathon Petroleum NYSE: MPC on 8/14/2025.
  • Purchased $15,001 - $50,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
  • Purchased $1,001 - $15,000 in shares of Prologis NYSE: PLD on 8/14/2025.
  • Purchased $1,001 - $15,000 in shares of Visa NYSE: V on 8/13/2025.

Procter & Gamble Stock Down 1.2%

Shares of NYSE:PG opened at $150.67 on Thursday. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The company's fifty day moving average is $155.26 and its 200-day moving average is $159.72. The company has a market capitalization of $352.64 billion, a PE ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the previous year, the business posted $1.40 earnings per share. The firm's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on PG. Wells Fargo & Company cut their price target on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a report on Thursday, September 25th. Evercore ISI reaffirmed an "in-line" rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Bank of America dropped their price objective on Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a report on Wednesday. Berenberg Bank boosted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a report on Wednesday, September 17th. Finally, BNP Paribas Exane dropped their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a report on Tuesday, September 23rd. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and an average price target of $172.58.

Get Our Latest Stock Analysis on Procter & Gamble

Insider Buying and Selling

In other news, CEO Jon R. Moeller sold 11,684 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer owned 319,932 shares in the company, valued at $48,703,248.36. The trade was a 3.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Balaji Purushothaman sold 490 shares of the business's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider owned 12,616 shares of the company's stock, valued at $1,920,533.68. This trade represents a 3.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 over the last ninety days. 0.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC raised its holdings in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Norges Bank bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at $5,099,644,000. Nuveen LLC bought a new stake in shares of Procter & Gamble in the 1st quarter valued at $1,954,941,000. Laurel Wealth Advisors LLC increased its stake in shares of Procter & Gamble by 15,971.7% in the 2nd quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company's stock valued at $1,117,270,000 after acquiring an additional 6,969,110 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Procter & Gamble by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company's stock valued at $37,155,222,000 after acquiring an additional 3,189,111 shares in the last quarter. Institutional investors own 65.77% of the company's stock.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio's 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Taylor (Republican Party) ran for election to the U.S. House to represent Ohio's 2nd Congressional District. He won in the general election on November 5, 2024. David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor's career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

Procter & Gamble Company Profile

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.